Florence Assan
YOU?
Author Swipe
View article: Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment
Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment Open
View article: LB1726 Pathogenic contribution of ADAR1 mutations to severe plaque psoriasis
LB1726 Pathogenic contribution of ADAR1 mutations to severe plaque psoriasis Open
View article: Serum infliximab levels and clinical response in hidradenitis suppurativa
Serum infliximab levels and clinical response in hidradenitis suppurativa Open
Background Infliximab (IFX) is a chimeric immunoglobulin G‐1κ monoclonal antibody that neutralises the biologic activity of tumour necrosis factor‐α, and has shown efficacy (off‐label) for the treatment of severe hidradenitis suppurativa (…
View article: Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort Open
Background Acral pustular disease within the pustular psoriasis/psoriasis‐like spectrum mainly includes palmoplantar pustulosis (PPP) and acrodermatitis continua of Hallopeau (ACH). Scarce data argue for a distinction between these two ent…
View article: Poussée sévère de DITRA causée par le SARS-CoV-2
Poussée sévère de DITRA causée par le SARS-CoV-2 Open
View article: SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist Open
View article: Response to “New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019”
Response to “New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019” Open
View article: European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance Open
View article: Supplementary Material for: First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq
Supplementary Material for: First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq Open
Background: Obesity is associated with an increased risk of psoriasis. Objective: In this study, we examined whether body mass index (BMI) is taken into account when choosing first-line biologic therapy for psor…
View article: Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study
Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study Open
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a current pandemic worldwide. This virus can reach all organs and disturbs the immune system, leading to a cytokine storm in severe forms. We aimed to …
View article: Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities Open
View article: Reply
Reply Open
View article: O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease
O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease Open
Background Supported by both the ACR and EULAR, the EULAR/ACR 2019 Classification Criteria for SLE employ positive ANA (ever) as an entry criterion and use a weighted scheme with values ranging from 2 to 10, for a classification cut-off of…
View article: Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa
Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa Open
View article: Echocardiographic features in antiphospholipid-negative Sneddon’s syndrome and potential association with severity of neurological symptoms or recurrence of strokes: a longitudinal cohort study
Echocardiographic features in antiphospholipid-negative Sneddon’s syndrome and potential association with severity of neurological symptoms or recurrence of strokes: a longitudinal cohort study Open
Aims Sneddon’s syndrome (SS) may be classified as antiphospholipid positive (aPL+) or negative (aPL− SS). An association between Libman–Sacks (LS) endocarditis and strokes has been described in aPL+ patients. To describe cardiac involvemen…
View article: 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus Open
Objective To develop new classification criteria for systemic lupus erythematosus ( SLE ) jointly supported by the European League Against Rheumatism ( EULAR ) and the American College of Rheumatology ( ACR ). Methods This international in…
View article: 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus Open
View article: SAT0192 MYOSITIS IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME: DATA FROM A FRENCH NATIONWIDE SURVEY
SAT0192 MYOSITIS IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME: DATA FROM A FRENCH NATIONWIDE SURVEY Open